GlaxoSmithKline Says Albrecht Doesn’t Allow Paxil Suicide Verdict To Be Reinstated
CHICAGO — GlaxoSmithKline (GSK) in a July 8 brief tells an Illinois federal court that the U.S. Supreme Court’s recent ruling on the “clear evidence” standard for drug warning label cases...To view the full article, register now.
Already a subscriber? Click here to view full article